• Citer

Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial

par Llombart-Cussac, Antonio;Prat, Aleix;Pérez-García, José Manuel;Mateos, José;Pascual, Tomás;Escrivá-de-Romani, Santiago;Stradella, Agostina;Ruiz Borrego, Manuel;de las Heras, Begoña;Keyaerts, Marleen;Galvan, Patricia;Brasó-Maristany, Fara;García-Mosquera, Juan José;Guiot, Thomas ;Gion, María;Sampayo-Cordero, Miguel;Di Cosimo, Serena;Pérez-Escuredo, Jhudit;de Frutos, Manuel Atienza;Cortes, Javier;Gebhart, Géraldine
Référence European journal of nuclear medicine and molecular imaging
Publication Publié, 2024

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial
Auteur:	Llombart-Cussac, Antonio; Prat, Aleix; Pérez-García, José Manuel; Mateos, José; Pascual, Tomás; Escrivá-de-Romani, Santiago; Stradella, Agostina; Ruiz Borrego, Manuel; de las Heras, Begoña; Keyaerts, Marleen; Galvan, Patricia; Brasó-Maristany, Fara; García-Mosquera, Juan José; Guiot, Thomas; Gion, María; Sampayo-Cordero, Miguel; Di Cosimo, Serena; Pérez-Escuredo, Jhudit; de Frutos, Manuel Atienza; Cortes, Javier; Gebhart, Géraldine
Informations sur la publication:	European journal of nuclear medicine and molecular imaging
Statut de publication:	Publié, 2024
Sujet CREF:	Imagerie médicale, radiologie, tomographie
Mots-clés:	Disease detection
	Early breast cancer
	HER2-positive
	Predictors
	[18F]FDG-PET
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1619-7070
	info:doi/10.1007/s00259-024-06683-0
	info:scp/85189686448